Drug May Be Safer Option Against Repeat Stroke
The risk of another stroke caused by a blood clot was halved for patients who took the drug Pletal plus aspirin or clopidogrel, versus those who took aspirin or clopidogrel alone. (Source: WebMD Health)
Source: WebMD Health - February 7, 2019 Category: Consumer Health News Source Type: news
Dual Antiplatelet Therapy With Cilostazol Cuts Recurrent Stroke Dual Antiplatelet Therapy With Cilostazol Cuts Recurrent Stroke
New results show cilostazol plus aspirin or clopidogrel reduced recurrent stroke rate by half over aspirin or clopidogrel alone in high-risk stroke patients without increased bleeding.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Blood Thinning Drug May Be Safer Option Against Recurrent Stroke
THURSDAY, Feb. 7, 2019 -- Taking the blood thinner Pletal (cilostazol) with either aspirin or clopidogrel (best known as Plavix) lowers stroke patients ' risk of a subsequent stroke better than taking aspirin or clopidogrel alone, a new study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 7, 2019 Category: General Medicine Source Type: news
Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke
(American Heart Association) The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news
Clopidogrel vs aspirin in acute coronary syndrome in China
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2018 Category: Drugs & Pharmacology Source Type: news
Risk of Adverse CV Events With PPIs Independent of Clopidogrel Risk of Adverse CV Events With PPIs Independent of Clopidogrel
This study aimed to determine whether the observed increase in cardiovascular risk of PPI use with anti-platelet therapy is conferred by PPIs directly or by a pharmacokinetic interaction.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Modern antiplatelet therapy: When is clopidogrel the right choice?
(Cardiovascular Innovations and Applications) In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 2, 2018, pp. 149-162(14); DOI: 10.15212/CVIA.2017.0049 Punag Divanji and Kendrick Shunk from the University of California San Francisco and The San Francisco Veteran Affairs Hospital, San Francisco, Calif., USA consider when clopidogrel is the right choice in modern antiplatelet therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 10, 2018 Category: International Medicine & Public Health Source Type: news
Plavix and TTP
Title: Plavix and TTPCategory: Doctor's& Expert's views on SymptomsCreated: 5/10/2000 4:41:00 PMLast Editorial Review: 6/13/2018 2:55:08 PM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 13, 2018 Category: Drugs & Pharmacology Source Type: news
Stroke After PCI Linked to Platelet Reactivity on Plavix
(MedPage Today) -- But it ' s unclear whether link seen in post hoc analysis would be actionable (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 7, 2018 Category: Cardiology Source Type: news
Many Prescriptions for Newer, More Expensive Antiplatelet Agents Go Unfilled Many Prescriptions for Newer, More Expensive Antiplatelet Agents Go Unfilled
Prescriptions for the P2Y12 inhibitors prasugrel hydrochloride and ticagrelor hydrochloride after percutaneous coronary intervention (PCI) are outpacing those for clopidogrel, but many patients are not filling those prescriptions, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
POINT: Success at Last for Dual Antiplatelet After Stroke, TIA POINT: Success at Last for Dual Antiplatelet After Stroke, TIA
A combination of clopidogrel plus aspirin reduced major ischemic events vs aspirin alone in patients with minor ischemic stroke or high-risk TIA in this long-awaited trial.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Clopidogrel & #43; Aspirin Cuts Ischemic Events in Stroke, TIA
THURSDAY, May 17, 2018 -- The combination of clopidogrel and aspirin is associated with reduced risk of major ischemic events but increased risk of major hemorrhage among patients with minor ischemic stroke or high-risk transient ischemic attack... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2018 Category: Pharmaceuticals Source Type: news
International study suggests combination therapy may prevent stroke in certain people
(NIH/National Institute of Neurological Disorders and Stroke) Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days. The combination therapy was also associated with an increase in major bleeding, although many of those episodes were non-fatal and did not occur in the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news
After'Mini-Stroke,' Drug Combo (Aspirin Plus Clopidogrel) Could Help Cut Odds for Major Attack
WEDNESDAY, May 16, 2018 -- A dual-drug approach after a " mini-stroke " might maximize a person ' s odds of avoiding a more major stroke in the months after, research shows.
Minor strokes and events known as " transient ischemic attacks " (TIA), or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 16, 2018 Category: General Medicine Source Type: news
Stroke prevention drug combo shows promise
If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine. (Source: World Pharma News)
Source: World Pharma News - May 16, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
